Paul Maier - H-M

Paul Maier



Paul V. Maier has over 25 years of experience as a senior executive in biotechnology and pharmaceutical companies and nearly 15 years of experience as a Director of multiple life science public and private company Boards.  In addition to his Board positions, Mr. Maier also currently serves as an advisor to the life science industry.  In June 2014, Mr. Maier retired after serving since November 2009 as Chief Financial Officer of Sequenom, Inc., a publically held company serving the discovery, clinical research, and molecular diagnostics market.  From February 2007 until November 2009, Mr. Maier served as an independent financial consultant.  Previously, Mr. Maier was Senior Vice President and Chief Financial Officer of Ligand Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, a position he held from 1992 to 2007.  From 1990 to 1992, Mr. Maier served as Vice President, Finance of DFW West, a division of DFS Group, LP a private multinational retailer.  From 1984 to 1990, Mr. Maier was employed by ICN Pharmaceuticals, a pharmaceutical and biotechnology research products company, where he held various executive positions in finance and general management in ICN as well as SPI Pharmaceuticals, a publically held subsidiary.  Mr. Maier currently serves on the Board of Directors of Apricus Biosciences, International Stem Cell Corporation, Mabvax Therapeutics, Biological Dynamics, and Ritter Pharmaceuticals. 

Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University.